DK0675897T3 - Nye steroider - Google Patents

Nye steroider

Info

Publication number
DK0675897T3
DK0675897T3 DK94903944.0T DK94903944T DK0675897T3 DK 0675897 T3 DK0675897 T3 DK 0675897T3 DK 94903944 T DK94903944 T DK 94903944T DK 0675897 T3 DK0675897 T3 DK 0675897T3
Authority
DK
Denmark
Prior art keywords
formula
compounds
preparation
image
methods
Prior art date
Application number
DK94903944.0T
Other languages
English (en)
Inventor
Michael John Ashton
Sven Jan-Anders Karlsson
Bernard Yvon Jack Vacher
Michael Thomas Withnall
Original Assignee
Rhone Poulenc Rorer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929226917A external-priority patent/GB9226917D0/en
Priority claimed from GB939303121A external-priority patent/GB9303121D0/en
Application filed by Rhone Poulenc Rorer Ltd filed Critical Rhone Poulenc Rorer Ltd
Application granted granted Critical
Publication of DK0675897T3 publication Critical patent/DK0675897T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0092—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by an OH group free esterified or etherified

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK94903944.0T 1992-12-24 1993-12-24 Nye steroider DK0675897T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929226917A GB9226917D0 (en) 1992-12-24 1992-12-24 Novel compositions of matter
GB939303121A GB9303121D0 (en) 1993-02-17 1993-02-17 Novel compositions of matter
PCT/GB1993/002659 WO1994014834A1 (en) 1992-12-24 1993-12-24 New steroids

Publications (1)

Publication Number Publication Date
DK0675897T3 true DK0675897T3 (da) 1998-01-26

Family

ID=26302221

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94903944.0T DK0675897T3 (da) 1992-12-24 1993-12-24 Nye steroider

Country Status (19)

Country Link
US (1) US5801165A (da)
EP (1) EP0675897B1 (da)
JP (1) JP2657982B2 (da)
KR (1) KR960700265A (da)
AT (1) ATE154607T1 (da)
AU (1) AU672669B2 (da)
CA (1) CA2149777C (da)
CZ (1) CZ159195A3 (da)
DE (1) DE69311742T2 (da)
DK (1) DK0675897T3 (da)
ES (1) ES2107806T3 (da)
FI (1) FI953130A0 (da)
GR (1) GR3024641T3 (da)
HU (1) HUT72442A (da)
IL (1) IL108167A0 (da)
NO (1) NO952532L (da)
NZ (1) NZ259401A (da)
PL (1) PL309402A1 (da)
WO (1) WO1994014834A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9507135D0 (en) * 1995-04-06 1995-05-31 Rh Ne Poulenc Rorer Limited Chemical compounds
WO1997024368A1 (en) * 1995-12-29 1997-07-10 Glaxo Group Limited 17beta-(2-oxo-tetrahydrofuran-4-yl)-thio-androstane derivatives (17beta-(gamma-butyric acid lactone)-thio derivatives) for the treatment of inflammation and pharmaceutical compositions and a process for the production thereof
CN1245982C (zh) 1996-05-09 2006-03-22 阿姆瑞德手术有限公司 哮喘和气道疾病的治疗
HRP20010018A2 (en) 2001-01-09 2002-12-31 Pliva D D Novel anti-inflammatory compounds
RS20050008A (sr) 2002-07-08 2007-06-04 Pliva-Istraživački Institut D.O.O., Nova jedinjenja,kompozicije i metode za lečenje inflamatornih oboljenja i stanja
AU2003264917A1 (en) 2002-07-08 2004-01-23 Pliva - Istrazivacki Institut D.O.O. Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules
HRP20030324A2 (en) 2003-04-24 2005-02-28 Pliva-Istra�iva�ki institut d.o.o. Compounds of antiinflammatory effect
HRP20030604A2 (en) 2003-07-25 2005-04-30 Pliva-Istra�iva�ki institut d.o.o. Substituted furochromenes, preparation thereof andtheir antiinflammatory action
HRP20030603A2 (en) 2003-07-25 2005-10-31 Pliva-Istra�iva�ki institut d.o.o. Substituted furochromene compounds of antiinflammatory action
ES2337915T3 (es) 2004-10-27 2010-04-30 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Conjugados con adtividad antiinflamatoria.
GB0520794D0 (en) * 2005-10-12 2005-11-23 Innovata Biomed Ltd Inhaler
PT105138B (pt) * 2010-06-01 2012-11-06 Hovione Farmaciencia S A Método para a preparação de compostos orgânicos monofluorometilados biologicamente activos
PT105723B (pt) * 2011-05-26 2014-03-24 Hovione Farmaci Ncia S A Método para a preparação de compostos orgânicos biologicamente activos

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3198792A (en) * 1962-06-12 1965-08-03 Philips Corp 10alpha methyl, 9beta hormonal steroids
SE378109B (da) * 1972-05-19 1975-08-18 Bofors Ab
US4933168A (en) * 1975-05-27 1990-06-12 Syntex Pharmaceuticals International Limited Stable, crystalline flunisolide
US4188385A (en) * 1978-04-05 1980-02-12 Syntex (U.S.A.) Inc. Thioetianic acid derivatives
GB2137206B (en) * 1980-02-15 1985-04-03 Glaxo Group Ltd Androstane 17-carbothioc acid derivatives
SE8008524L (sv) * 1980-12-04 1982-06-05 Draco Ab 4-pregnen-derivat, ett forfarande for deras framstellning, beredning och metod for behandling av inflammatoriska tillstand
US4361559A (en) * 1981-08-20 1982-11-30 E. R. Squibb & Sons, Inc. Antiinflammatory 17,17-bis (substituted thio) androstenes
HU182775B (en) * 1981-10-15 1984-03-28 Richter Gedeon Vegyeszet Process for preparing new 3-chloro-pregnane derivatives
US4481144A (en) * 1984-02-03 1984-11-06 E. R. Squibb & Sons, Inc. 17-Substituted thia-17-alkyl(or alkenyl or alkynyl)androstenes
US4499021A (en) * 1984-04-12 1985-02-12 E. R. Squibb & Sons, Inc. 17β(Substituted thio)-16-ketoandrostene-17α..-carboxylic acid derivatives
US4528138A (en) * 1984-06-20 1985-07-09 E. R. Squibb & Sons, Inc. 16-Keto-17-substituted thia-17-alkyl(or alkenyl or alkynyl) androstenes
US4529547A (en) * 1984-06-20 1985-07-16 E.R. Squibb & Sons, Inc. 17-(substituted thio)-17-(substituted dithio)androstenes
SE8501693D0 (sv) * 1985-04-04 1985-04-04 Draco Ab Novel 16,17-acetalsubstituted androstane-17beta-carboxylic acid esters
US4868170A (en) * 1987-11-13 1989-09-19 E. R. Squibb & Sons, Inc. Steriod lotion formulation
US4868169A (en) * 1987-11-13 1989-09-19 E. R. Squibb & Sons, Inc. Steroid cream formulation
US4883792A (en) * 1989-01-17 1989-11-28 Peter Timmins Steroid cream formulation

Also Published As

Publication number Publication date
NZ259401A (en) 1996-10-28
DE69311742D1 (de) 1997-07-24
EP0675897A1 (en) 1995-10-11
IL108167A0 (en) 1994-04-12
EP0675897B1 (en) 1997-06-18
JPH08504806A (ja) 1996-05-28
GR3024641T3 (en) 1997-12-31
DE69311742T2 (de) 1998-01-08
CZ159195A3 (en) 1996-03-13
PL309402A1 (en) 1995-10-02
ATE154607T1 (de) 1997-07-15
US5801165A (en) 1998-09-01
AU672669B2 (en) 1996-10-10
FI953130L (fi) 1995-06-22
HUT72442A (en) 1996-04-29
CA2149777A1 (en) 1994-07-07
JP2657982B2 (ja) 1997-09-30
WO1994014834A1 (en) 1994-07-07
ES2107806T3 (es) 1997-12-01
NO952532D0 (no) 1995-06-23
FI953130A7 (fi) 1995-06-22
NO952532L (no) 1995-08-24
HU9501876D0 (en) 1995-08-28
FI953130A0 (fi) 1995-06-22
CA2149777C (en) 2004-05-25
AU5819694A (en) 1994-07-19
KR960700265A (ko) 1996-01-19

Similar Documents

Publication Publication Date Title
ATE181551T1 (de) Taxol-derivate
DE59108530D1 (de) Antimikrobielle Mittel sowie substituierte 2-Cyclohexan-1-yl-amin-Derivate und deren Herstellung
DK0675897T3 (da) Nye steroider
ATE129503T1 (de) Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel als antikoagulantien.
CA2076589A1 (en) Naphthylethylureas and naphthylethylthioureas, the process for their preparation and pharmaceutical compositions holding same
ES2051650A1 (es) Procedimiento para preparar un limpiador de oxigeno activo.
ATE17715T1 (de) N-phenyl-benzamid-derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel.
BR1100061A (pt) Composto, processo para a preparação do mesmo, composição e uso dos mesmos
DE69318238D1 (de) Benzopyran-Verbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung als Zellenschutzmittel
NO951484D0 (no) Kinolon- og akridinon-derivater for behandling av urininkontinens
AU656466B2 (en) New benzimidazole compounds, a process for their preparation and pharmaceutical compositions containing them
DE69528983D1 (de) Indolalkaloide als antientzündliche wirkstoffe
KR960703863A (ko) 암 치료용 신규 비스-나프탈이미드(New Bis-naphthalimides for the Treatment of Cancer)
ES2104174T3 (es) Derivados de bencilamino, bencilamido y bencilimido ciclicos utilizados como agentes antipsicoticos.
AU3350195A (en) Bicyclic carboxamides as 5-HT-1A antagonists
AU553493B2 (en) 3,7alpha-diazacyclohepta(j,k)fluoriene derivatives